Clinical Experience with High-Dose Polymyxin B against Carbapenem-Resistant Gram-Negative Bacterial Infections—A Cohort Study

Population pharmacokinetic studies have suggested that high polymyxin B (PMB) doses (≥30,000 IU/kg/day) can improve bacterial kill in carbapenem-resistant Gram-negative bacteria (CR-GNB). We aim to describe the efficacy and nephrotoxicity of patients with CR-GNB infections prescribed high-dose PMB....

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Antibiotics (Basel)
Glavni autori: Cai, Yiying, Leck, Hui, Tan, Ray W., Teo, Jocelyn Q., Lim, Tze-Peng, Lee, Winnie, Chlebicki, Maciej Piotr, Kwa, Andrea L.
Format: Artigo
Jezik:Inglês
Izdano: MDPI 2020
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7459528/
https://ncbi.nlm.nih.gov/pubmed/32726974
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/antibiotics9080451
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items